72 filings
6-K
ENTX
Entera Bio Ltd
10 Nov 21
Condensed Consolidated Interim Financial Statements
8:32am
6-K
ENTX
Entera Bio Ltd
10 Nov 21
Entera Bio Reports Third Quarter 2021 Financial Results
8:30am
6-K
ENTX
Entera Bio Ltd
28 Oct 21
Current report (foreign)
8:30am
6-K
ENTX
Entera Bio Ltd
14 Oct 21
Current report (foreign)
6:30am
6-K
ENTX
Entera Bio Ltd
6 Oct 21
Entera Bio Presents Positive Phase 2 6-Month Bone Mineral Density Data for Oral PTH
8:30am
6-K
ya8li lzeg
1 Sep 21
Entera Bio Selected for Late Breaking Oral Presentation of Phase 2
8:30am
6-K
kozzmq kxae4a
27 Aug 21
Current report (foreign)
5:28pm
6-K
v0ctwob4 cjc
23 Aug 21
Current report (foreign)
11:15am
6-K
p1g alqufr04i31wk
23 Aug 21
Entera Bio to Present at H.C. Wainwright 23rd Annual Global Investment Conference
8:30am
6-K
zwikpu30gen
16 Aug 21
Current report (foreign)
6:31am
6-K
8uemtp xo7uc7x
16 Aug 21
Entera Bio Reports Second Quarter 2021 Financial Results and Provides
6:30am
6-K
kse9 whve1
2 Aug 21
Current report (foreign)
8:30am
6-K
ejk8b
23 Jun 21
Entera Bio Announces Excellent Topline Phase 2 BMD Data for EB613, the The study’s primary efficacy endpoint, a statistically significant increase in P1NP at 3 months was achieved, as previously reported
8:30am
6-K
cbcfo4ldvdkk51zuov
22 Jun 21
At Market Issuance Sales Agreement
5:25pm
6-K
guaf6zojrtzd27i
17 Jun 21
Entera Bio Receives Foundational Patent for its Oral PTH using its Platform
8:02am
6-K
wju mz031fom9f8
20 May 21
Condensed Consolidated Interim Financial Statements
8:02am
6-K
8lgbhye3dmpio8ajpoq
20 May 21
Entera Bio Reports First Quarter 2021 Financial Results and Provides
8:00am
6-K
tdb z6jeem576
20 Apr 21
Entera Announces Ron Mayron, a Global Pharma Leader, Joins its Board of Directors
8:30am
6-K
29ng5ek 6h5r
15 Apr 21
Entera Appoints Ramesh Ratan As Chief Financial Officer
8:30am
6-K
c4ra2r7zt0uooa 9dia
6 Apr 21
New Data Suggest Entera’s Platform Orally Delivers Human Growth Hormone, Study
8:30am